Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
-
+
EP14.01-001 - SCLC Transformation from ALK-rearranged Lung Adenocarcinoma after Alectinib Resistance and Response to Atezolizumab: Case Report
Presenter: Guohao Xia- Abstract
Loading... -
+
EP14.01-002 - Efficacy and Safety of Tiselizumab Combined with Anlotinib and 2-cycle Irinotecan as Second-line Treatment of Small Cell Lung Cancer
Presenter: xian chen- Abstract
Loading... -
+
EP14.01-003 - Parotid Metastases from Primary Lung Cancer: Case Series and Systematic Review on the Clinical Features
Presenter: Rulan Wang- Abstract
Loading... -
+
EP14.01-005 - Weekly Sequential ACOCEV Chemotherapy (ADR, CTX, CBDCA, VP16, VCR) for Elderly - Poor PS SCLC Patients: An Observational Study
Presenter: Antonio Santo- Abstract
Loading... -
+
EP14.01-006 - CeLEBrATE: Phase II trial of CarbopLatin, Etoposide, Bevacizumab and Atezolizumab in Patients with exTEnsive-Stage SCLC-GOIRC-01-2019
Presenter: Giuseppe Lamberti- Abstract
Loading... -
+
EP14.01-007 - Next-Generation Sequencing to Dynamically Detect Mechanisms of Resistance to ALK Inhibitors in ALK-positive SCLC Patient: A Case Report
Presenter: Renhong Guo- Abstract
Loading... -
+
EP14.01-008 - Checkpoint Inhibitors Prevent New Onset of Brain Metastases in Relapsed Extensive Disease Small-Cell Lung Cancer
Presenter: Jan Alexander Stratmann- Abstract
Loading... -
+
EP14.01-009 - A Comparative Study of Histological Predictors of Outcome in Patients with Lung Typical and Atypical Carcinoids
Presenter: Joana Rei- Abstract
Loading... -
+
EP14.01-010 - CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
Presenter: Ying Cheng- Abstract
Loading... -
+
EP14.01-011 - Carcinoid Tumor of the Lung with Osteomimicry. Case Report
Presenter: Lovorka Batelja Vuletic- Abstract
Loading... -
+
EP14.01-012 - A Case Report of Lung Large Cell Neuroendocrine Carcinoma with Carcinoid Morphology
Presenter: Lovorka Batelja Vuletic- Abstract
Loading... -
+
EP14.01-013 - First-Line Chemotherapy vs Chemoimmunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung, a Retrospective Study
Presenter: Lingbin Meng- Abstract
Loading... -
+
EP14.01-014 - Risk Factors for Brain Metastasis in Patients with Small Cell Lung Cancer: A Systematic Review and Meta-analysis
Presenter: Lizza Hendriks- Abstract
Loading... -
+
EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC
Presenter: Luis Paz-Ares- Abstract
Loading... -
+
EP14.01-016 - Anlotinib Plus Toripalimab as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer: a Single-Arm Phase II Study
Presenter: Dongqing Lv- Abstract
Loading... -
+
EP14.01-018 - Small Cell Lung Carcinoma in Morocco
Presenter: Ouassima Erefai- Abstract
Loading... -
+
EP14.01-019 - Identifying Circulating DNA Methylation Patterns in Small Cell Lung Cancer Patients
Presenter: Sami Ul Haq- Abstract
Loading... -
+
EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer
Presenter: Stephen V. Liu- Abstract
Loading... -
+
EP14.01-021 - Anlotinib Plus Irinotecan or Docetaxel in Small-Cell Lung Cancer (SCLC) Relapsed within Six Months: a Single-Arm Phase II Study
Presenter: Bing Xia- Abstract
Loading... -
+
EP14.01-022 - Immune Thrombocytopenia in a Patient with Large Cell Neuroendocrine Carcinoma Under Dual Immune Checkpoint Inhibition
Presenter: Ioannis Gkiozos- Abstract
Loading... -
+
EP14.01-023 - A Randomized Phase II Study of Irinotecan Plus Cisplatin With or Without Simvastatin in Ever-Smoking Small Cell Lung Cancer
Presenter: Youngjoo Lee- Abstract
Loading... -
+
EP14.01-024 - Transformation of SCLC to Lung Squamous Cell Carcinoma after First-Line Chemotherapy and Response to Sintilimab: A Case Report
Presenter: Zhisheng Liu- Abstract
Loading... -
+
EP14.01-025 - Anlotinib Plus Standard Chemotherapy as First-line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
Presenter: Wei Zhang- Abstract
Loading...
-
+
EP14.02 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Preclinical/Translational
-
+
EP14.02-001 - Could the Oxidative Stress Be Used as a Marker for Neuroendocrine Lung Tumors?
Presenter: Luigi Gaetano Andriolo- Abstract
Loading... -
+
EP14.02-002 - Cisplatin in Combination with Entinostat exerts Synergistic Antineoplastic Activity in Small Cell Lung Cancer
Presenter: Anna Schwendenwein- Abstract
Loading... -
+
EP14.02-003 - Clinical Significance of MYC Family Members in Surgically Resected Limited-Stage Small Cell Lung Cancer: A Multicenter Study
Presenter: Christian Lang- Abstract
Loading... -
+
EP14.02-004 - Barasertib Inhibits the Growth of SCLC Cell Lines and Transformed SCLC Patient Derived Model In Vitro and In Viv
Presenter: Jin Soo Kim- Abstract
Loading... -
+
EP14.02-005 - Therapeutic targeting Mevalonate-Geranylgeranyl Diphosphate Pathway with Statins Overcomes Chemotherapy-resistance in SCLC
Presenter: Chenchen Guo- Abstract
Loading... -
+
EP14.02-006 - Subtype-specific Hypersensitivity to Oxidative Phosphorylation Inhibition in Small Cell Lung Cancer
Presenter: Kristiina Boettiger- Abstract
Loading... -
+
EP14.02-007 - Hes1 Protein Expression and Its Significance in Resected Small Cell Lung Cancers
Presenter: xujie Sun- Abstract
Loading...
-
+
EP14.03 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
-
+
EP14.03-001 - DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive Stage Small Cell Lung Cancer
Presenter: Aditya Juloori- Abstract
Loading... -
+
EP14.03-002 - Low-Dose Radiotherapy Plus Sugemalimab in Second-Line Treatment for Advanced-Stage Small-Cell Lung Cancer: Initial Results of a Phase I Study
Presenter: Youling Gong- Abstract
Loading... -
+
EP14.03-003 - Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Presenter: Neal Sean Mccall- Abstract
Loading... -
+
EP14.03-004 - Neuro-cognitive Effect of HS-PCI in LS-SCLC
Presenter: Suryakanta Acharya- Abstract
Loading... -
+
EP14.03-005 - Role of Radiotherapy Fraction in Limited-Stage SCLC: a Meta-Analysis of 8585 Reconstructed Individual Patient Data
Presenter: Jingjing Zhao- Abstract
Loading...
-
+
EP14.04 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW
-
+
EP14.04-001 - Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)
Presenter: Sara Mieko Moore- Abstract
Loading... -
+
EP14.04-002 - The Impact of Response on Survival in Extensive-Stage Small-Cell Lung Cancer in the CASPIAN Study
Presenter: Sukhvinder Johal- Abstract
Loading...
-
+
EP14.05 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
-
+
EP14.05-001 - Chemoimmunotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer and ECOG Performance Status of 2 or 3
Presenter: Muskan Agarwal- Abstract
Loading... -
+
EP14.05-002 - Impact of Body Mass Index on Survival in Patients with Small Cell Lung Cancer
Presenter: Alejandro Rios-Hoyo- Abstract
Loading... -
+
EP14.05-003 - Recent Stage Shifts and Changes in the Treatment of Stage I Small Cell Lung Cancer in the United States
Presenter: Chinmay Satish Haridas- Abstract
Loading... -
+
EP14.05-004 - Temozolomide and Atezolizumab as Second Line Treatment for Extensive Stage Small Cell Lung Cancer: A Randomized, Multi-Cohort Phase 2 Trial
Presenter: Dwight H Owen- Abstract
Loading... -
+
EP14.05-005 - Survival of Small Cell Lung Cancer in Relation to Chemotherapy Dose Intensity
Presenter: Elisa María Fernández Pérez- Abstract
Loading... -
+
EP14.05-006 - The Impact of Adjuvant Chemotherapy on Survival of Stage I Lung Large Cell Neuroendocrine Carcinoma: A Meta-Analysis of Comparative Studies
Presenter: Philip A Haddad- Abstract
Loading... -
+
EP14.05-007 - A Study of the Best Reduction in Target Lesion Size and Treatment Duration in the Durvalumab plus Platinum-Etoposide Regimen for ES-SCLC
Presenter: Kageaki Watanabe- Abstract
Loading... -
+
EP14.05-008 - Development of a Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Using Next-Generation Sequencing
Presenter: Hye Sook Kim- Abstract
Loading... -
+
EP14.05-009 - LUMINANCE: A Phase IIIb Study of Durvalumab + Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
Presenter: Niels Reinmuth- Abstract
Loading... -
+
EP14.05-010 - Real-World Eligibility for Clinical Trials in Extensive Stage Small Cell Lung Cancer Patients
Presenter: Navdeep Dehar- Abstract
Loading... -
+
EP14.05-011 - Real-World Impact of Platinum Sensitivity and Disease Stage on Survival Among Medicare Patients with Small Cell Lung Cancer
Presenter: Paul Cockrum- Abstract
Loading... -
+
EP14.05-012 - Comparing Costs for Medicare FFS Patients Treated with Etoposide or Irinotecan for Extensive Stage Small Cell Lung Cancer
Presenter: Paul Cockrum- Abstract
Loading... -
+
EP14.05-013 - Real-World Resource Use and Costs by Stage and Platinum Sensitivity among Medicare Patients with Small Cell Lung Cancer
Presenter: Paul Cockrum- Abstract
Loading... -
+
EP14.05-014 - Trends in Population Survival Among Adults Diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021
Presenter: Paul Cockrum- Abstract
Loading... -
+
EP14.05-015 - Quantifying Recent Trends in Real-World Treatment Patterns Among Adults Diagnosed with Small Cell Lung Cancer in the U.S. from 2013-2021
Presenter: Paul Cockrum- Abstract
Loading... -
+
EP14.05-016 - Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study.
Presenter: Robert Stirling- Abstract
Loading... -
+
EP14.05-017 - Real World Eligibility of Immune Checkpoint Inhibitors with Platinum-Doublet in Extensive Stage Small Cell Lung Cancer
Presenter: Rebekah Rittberg- Abstract
Loading... -
+
EP14.05-018 - Major Lung Resection for Carcinoid Tumor; Does It Affect Quality of Life?
Presenter: riad abdeljalil- Abstract
Loading... -
+
EP14.05-019 - Contemporary Real-World Adverse Events Associated with Small Cell Lung Cancer Diagnosed in a U.S. Population from 2013-2021
Presenter: Robert A Ramirez- Abstract
Loading... -
+
EP14.05-020 - Population-based Outcomes for Patients with Extensive-Stage Small-cell Lung Cancer from the Canadian SCLC Database (CASCADE)
Presenter: Sara Mieko Moore- Abstract
Loading... -
+
EP14.05-021 - Promising Long-Term Survival after Surgical Resection of Early Stage Small Cell Lung Cancer in a Modern Single-Center Cohort
Presenter: Sora Ely- Abstract
Loading... -
+
EP14.05-022 - The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer
Presenter: Rei Takamiya- Abstract
Loading... -
+
EP14.05-023 - Characterization of Real-World Use of Lurbinectedin in Adult Small Cell Lung Cancer Patients in the United States
Presenter: Xue Wang- Abstract
Loading...
-
+
EP15.01 - Tobacco Control and Risk Reduction
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tobacco Control and Risk Reduction
-
+
EP15.01-001 - Ask, Advise, Help (AAH) Smoking Cessation Brief Advice Delivery in Patients with Diagnosed Lung Cancer: A Retrospective Audit
Presenter: John Lau- Abstract
Loading... -
+
EP15.01-002 - Lowering Rates of Smoking after Cancer Diagnosis: Use Social Networks
Presenter: Melissa Neumann- Abstract
Loading...
-
+
EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
EP16.01-001 - Transforming Growth Factor-βinhibitsInterferon- γmediated Immune Resistance in Lung Cancer
Presenter: ye fan- Abstract
Loading... -
+
EP16.01-002 - T Cell Receptor Diversity among Non-Small Cell Lung Cancer Patients Treated with Pembrolizumab Alone or in Combination with Chemotherapy.
Presenter: Afaf Abed- Abstract
Loading... -
+
EP16.01-003 - The Dynamic Immune Signature of Patients with Advanced Non-small Cell Lung Cancer in Prediction of Infection After Receiving Immunotherapy
Presenter: Chia-I Shen- Abstract
Loading... -
+
EP16.01-004 - Pleural Mesotheliomas Related with Geographical Asbestos Exposure Show Higher PD-L1 Expression
Presenter: Yusuf Kahya- Abstract
Loading... -
+
EP16.01-005 - Cilia-related mRNA Profile Predicts Clinical Response to PD-1 Blockade in Lung Adenocarcinoma
Presenter: Guanghui Gao- Abstract
Loading... -
+
EP16.01-006 - CD47 Inhibition Impairs the Growth of Orthotopic, Immune Competent Lung Tumour Models
Presenter: Kelsie Thu- Abstract
Loading... -
+
EP16.01-007 - Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
Presenter: Laura Gutiérrez Sainz- Abstract
Loading... -
+
EP16.01-008 - The Effect of Cytochrome P450 Family 4 Subfamily B Member 1 (CYP4B1) on Lung Adenocarcinoma (LUAD) Immune Microenvironment
Presenter: Leen Al-Kraimeen- Abstract
Loading... -
+
EP16.01-009 - Two Novel Alternative Cell Line Models for the Study of Multiorganic Metastasis and Immunotherapy in Lung Squamous Cell Carcinoma
Presenter: Luis M Montuenga- Abstract
Loading... -
+
EP16.01-010 - A Machine-Learning Based Survival Prediction for Lung Adenocarcinma by Analyzing Infiltrated Lymphocytes Profiles with CIBERSORT
Presenter: Tong Lu- Abstract
Loading... -
+
EP16.01-011 - PD-L1 Expression on Cytological Imprints and Circulating Tumor Cells versus Standardized Immunohistochemistry in NSCLC
Presenter: Martin Reck- Abstract
Loading... -
+
EP16.01-012 - Immunophenotyping of Lung Adenocarcinoma in situ Based on CD8-positive T Cell Infiltration
Presenter: Yu Ma- Abstract
Loading... -
+
EP16.01-013 - The Diagnostic Accuracy of Tumor Mutational Burden in Advanced NSCLC: An Individual Patient Data Meta-Analysis
Presenter: Maria La Mantia- Abstract
Loading... -
+
EP16.01-014 - Characterisation of Circulating Immune Cells in a Cohort of Non-small Cell Lung Cancer Patients Treated with Immunotherapy
Presenter: Marta Gascón- Ruiz- Abstract
Loading... -
+
EP16.01-015 - Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Presenter: Maximilian Johannes Hochmair- Abstract
Loading... -
+
EP16.01-016 - Tumor Treating Fields (TTFields) Application Promotes a Pro-inflammatory Phenotype in Macrophages
Presenter: Moshe Giladi- Abstract
Loading... -
+
EP16.01-017 - T-cell Repertoire Heterogeneity and Homogeneity in Synonymous Multiple Primary Lung Cancers
Presenter: Naixin Liang- Abstract
Loading... -
+
EP16.01-018 - SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC
Presenter: Sacha I Rothschild- Abstract
Loading... -
+
EP16.01-019 - The Role of the Pregnancy Associated Protein Glycodelin and Its Influence on the Immune System in Non-small-Cell Lung Cancer
Presenter: Sarah Richtmann- Abstract
Loading... -
+
EP16.01-020 - Predictive Effect of Spatial Protein Signature in Advanced NSCLC Receiving Immunotherapy with a Bispecific Antibody
Presenter: Xinyu Song- Abstract
Loading... -
+
EP16.01-021 - Less Immune Cell Infiltration and Worse Prognosis for NSCLC Patients with XPO1 Copy Number Alterations
Presenter: Xuanzong Li- Abstract
Loading... -
+
EP16.01-022 - A Signature of B Cells-Related Gene Pairs Predicts Oncologic Outcomes and Response to Immunotherapy in NSCLC Patients
Presenter: Xuanzong Li- Abstract
Loading... -
+
EP16.01-023 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma
Presenter: Yuan Li- Abstract
Loading... -
+
EP16.01-024 - Differential Efficacy of Combined GITR Co-stimulation with PD-1 Blockade in Preclinical Non-small Cell Lung Cancer Models
Presenter: Sheng Yan- Abstract
Loading... -
+
EP16.01-025 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
Presenter: Wen-Fang Tang- Abstract
Loading... -
+
EP16.01-027 - MIF ImprovesImmune Microenvironmentof Lewis Lung Cancer Brain Metastases after Radiotherapy ViaReducing M2 Macrophages
Presenter: Xiaorong Dong- Abstract
Loading... -
+
EP16.01-028 - Immunomodulatory Effects of Cryoablation Combined With Immune Checkpoint Inhibitors in a Murine Lung Cancer Model
Presenter: Yoshikane Yamauchi- Abstract
Loading... -
+
EP16.01-029 - Inter-tumor Heterogeneity of PD-L1 Expression in Non-small Cell Lung Cancer
Presenter: Yuichi Saito- Abstract
Loading... -
+
EP16.01-030 - Peripheral T-Cell Receptor Repertoire Profiling in Non-small Cell Lung Cancer Using an Amplicon-Based Sequencing Assay
Presenter: Zi Yi Wan- Abstract
Loading... -
+
EP16.01-031 - Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
Presenter: Sena Valcárcel González- Abstract
Loading... -
+
EP16.01-032 - Guiding Monotherapy with Docetaxel or Atezolizumab via the Tumour Mutation Index in Non-small Cell Lung Cancer Patients
Presenter: Baohui Han- Abstract
Loading... -
+
EP16.01-033 - Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated With Immunotherapy
Presenter: Andrea Sesma- Abstract
Loading...
-
+
EP16.02 - Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Minimally Invasive Biomarkers
-
+
EP16.02-001 - Integration of Primer Exchange Reaction and DNAzyme for Electrochemical Detection of PD-L1-Expressing Exosomes in Lung Cancer
Presenter: Bing Bo- Abstract
Loading... -
+
EP16.02-002 - Circulating Tumor DNA (ctDNA) Changes in Patients With Lung Cancer from a Real-World Prospective Clinico-Genomic (PCG) Study
Presenter: Anne Chiang- Abstract
Loading... -
+
EP16.02-003 - Real World Experience and Feasibility of Tissue Informed CGP and ctDNA Testing in a Cohort of NSCLC Patients
Presenter: Georges Azzi- Abstract
Loading... -
+
EP16.02-004 - Clinical Significance and Genomic Characteristics of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma
Presenter: Charles Ricordel- Abstract
Loading... -
+
EP16.02-005 - Liquid Biopsy Detects Genomic Drivers in Non-small Cell Lung Cancer without EGFR Mutations by Single-plex Testing: WJOG13620L
Presenter: Daisuke Hazama- Abstract
Loading... -
+
EP16.02-006 - Evaluation of Carcinoembryonic Antigen (CEA) as Predictive Marker in Patients with Metastatic Non-small Cell Lung Cancer
Presenter: Debapriya Mondal- Abstract
Loading... -
+
EP16.02-007 - Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
Presenter: Estela Sánchez-Herrero- Abstract
Loading... -
+
EP16.02-008 - Cerebrospinal Fluid as a Liquid Biopsy for Molecular Characterization of Brain Metastases in Patients With Non-small Cell Lung Cancer
Presenter: Georgios Tsakonas- Abstract
Loading... -
+
EP16.02-009 - Psychobiological Stress Responses to a Lung Cancer Diagnosis.
Presenter: Hronn Hardardottir- Abstract
Loading... -
+
EP16.02-010 - Predictive Value of Serum Reactive Oxygen Species Modulator 1 for Surgically Resected Lung Adenocarcinoma
Presenter: Seung Hyeun Lee- Abstract
Loading... -
+
EP16.02-011 - Liquid Biopsies in the Setting of Early-Stage Lung Cancer for the Detection of Actionable Mutations
Presenter: Joana Espiga de Macedo- Abstract
Loading... -
+
EP16.02-012 - cfDNA Analysis Implementation in Early Stage Lung Cancer
Presenter: Joana Espiga de Macedo- Abstract
Loading... -
+
EP16.02-013 - Retrospective Analysis of BRCA1/2 Alterations in Advanced NSCLC Using An Amplicon-based NGS Liquid Biopsy Assay
Presenter: Jonathan Poh- Abstract
Loading... -
+
EP16.02-014 - A Comparative Analysis of Gene Alteration Detected With NGS in Tumor Tissue and Peripheral Blood in Lung Cancer
Presenter: Laura Gutiérrez Sainz- Abstract
Loading... -
+
EP16.02-015 - Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC
Presenter: Loukia Georgiou Karacosta- Abstract
Loading... -
+
EP16.02-016 - Exploration of Factors Affecting the Performance of MRD Tumor-Informed Assay in Chinese Lung Cancer Patients
Presenter: Guomin Lin- Abstract
Loading... -
+
EP16.02-017 - Predictive Value of Peripheral Blood Immune Cell Profiling in EGFR-T790M Mutant Lung Adenocarcinoma
Presenter: Yutao Liu- Abstract
Loading... -
+
EP16.02-018 - Liquid Biopsies First to Make Treatment Decisions in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC)
Presenter: Luis Raez, MD, FACP, FCCP- Abstract
Loading... -
+
EP16.02-019 - Metabolic Changes in Sputum and Exhaled Breath Condensate of Non-small Cell Lung Cancer Patients after Surgical Resection
Presenter: Naseer Ahmed- Abstract
Loading... -
+
EP16.02-020 - Lung Cancer Cell Dynamics Significantly Depended on Blood Cell Circuit, Biochemical Factors, Hemostasis System, Cancer Characteristics
Presenter: Oleg Kshivets- Abstract
Loading... -
+
EP16.02-021 - The Expression of CEACAMs and Serum CEA Levels as Biomarkers of Postoperative Cancer Recurrence in Non-small Cell Lung Cancer
Presenter: Bubse Na- Abstract
Loading... -
+
EP16.02-022 - Circulating Tumor DNA Minimal Residual Disease Assay Predicts Outcome in Lung Cancer Patients Who Had Curative Treatments
Presenter: YOUJIN OH- Abstract
Loading... -
+
EP16.02-023 - Extracellular Vesicles Long RNA Sequencing as Diagnostic Biomarkers for Lung Adenocarcinoma Patients with Tumor Size Smaller than 2cm
Presenter: Fangfei Qian- Abstract
Loading... -
+
EP16.02-024 - Plasma ctDNA Organ-Specific Genomic Patterns and Origination Analysis in Advanced Non-Small Cell Lung Cancer
Presenter: Rui Fu- Abstract
Loading... -
+
EP16.02-025 - SerumTumor Markers as a Surrogate forRadiographicAssessment of Non-Small Cell Lung Cancer
Presenter: Scott W Strum- Abstract
Loading... -
+
EP16.02-026 - Dynamic Change of Indoleamine 2,3-dioxygenase Activity Predicts Survival in Radiotherapy- Received Unresectable Stage III NSCLC
Presenter: Linfang Wu- Abstract
Loading... -
+
EP16.02-027 - Targeted Methylation Analysis of Circulating Cell-Free DNA to Predict Outcomes in Clinical Stage I NSCLC Patients
Presenter: Yohan Bossé- Abstract
Loading... -
+
EP16.02-028 - Schwann Cell Exosomes Promote Lung Cancer Progression via miRNA-21-5P Cargo
Presenter: Yan Zhou- Abstract
Loading... -
+
EP16.02-029 - Plasma-Based Next Generation Sequencing for Molecular Characterization of Lung Adenocarcinoma: A Multicentric Cohort From Argentina
Presenter: Martina Paz Spotti- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-001 - High Frequency of KRAS Mutation, Uncommon EGFR Mutation and TMB-H in Xuanwei Female Patients With Lung Adenocarcinoma
Presenter: Heng Li- Abstract
Loading... -
+
EP16.03-002 - Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)
Presenter: Andres F Cardona- Abstract
Loading... -
+
EP16.03-003 - Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC)
Presenter: Andres F Cardona- Abstract
Loading... -
+
EP16.03-004 - Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition
Presenter: Alicia Isabell Tüns- Abstract
Loading... -
+
EP16.03-005 - Australian Non-Small Cell Lung Cancer (NSCLC) Biomarker Testing Practices - A Survey of Medical Oncologists and Pathologists
Presenter: Ben Markman- Abstract
Loading... -
+
EP16.03-006 - Genetic Characteristics of EGFR Concurrent Variants with RB1 and TP53 in NCSLC Patients
Presenter: Hui Chen- Abstract
Loading... -
+
EP16.03-007 - Comprehensive Analysis of m6A-Related Gene Mutation Characteristics and Prognosis in Lung Adenocarcinoma
Presenter: Jing-Hua Chen- Abstract
Loading... -
+
EP16.03-008 - The Landscape of NFE2L2 Alteration in Chinese Lung Cancer Patients
Presenter: Xuejun Dou- Abstract
Loading... -
+
EP16.03-009 - Patterns of KEAP1 Genomic Co-alterations in Advanced Non-small Cell Lung Cancer Identified by Plasma-Based Genyotyping
Presenter: Dwight H Owen- Abstract
Loading... -
+
EP16.03-010 - Molecular and Clinical Characterization of Lung Adenocarcinoma With Respect to Patient Age at Diagnosis
Presenter: Elsa Arbajian- Abstract
Loading... -
+
EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity
Presenter: Francesco Passiglia- Abstract
Loading... -
+
EP16.03-012 - Novel Human-derived EML4-ALK Fusion cell lines identify ribonucleotide reductase RRM2 as a Target of Activated ALK in NSCLC
Presenter: Ganesh Umapathy- Abstract
Loading... -
+
EP16.03-013 - Psychological Distress and Beta-2 Adrenergic Receptor Expression in Non-small Cell Lung Cancer Cells
Presenter: Hronn Hardardottir- Abstract
Loading... -
+
EP16.03-014 - Simultaneous Detection of FGFR Gene Aberrations in Squamous Non-small Cell Lung Cancer Using Targeted DNA- and RNA-based NGS
Presenter: Joanna Chorostowska-Wynimko- Abstract
Loading... -
+
EP16.03-015 - Centrosome Amplification Is a Prognostic Indicator and Potential Therapeutic Vulnerability in Non-small Cell Lung Cancer
Presenter: Kelsie Thu- Abstract
Loading... -
+
EP16.03-016 - Targetable Alterations in Non-Small Cell Lung Cancer According to Age and Sex
Presenter: ErinMarie O. Kimbrough- Abstract
Loading... -
+
EP16.03-017 - Spatial Heterogeneity of Tumor Microenvironment of Lung Adenocarcinoma Associated With Genomic Alterations
Presenter: Kwon Joong Na- Abstract
Loading... -
+
EP16.03-018 - Molecular Features of Subtypes Classified Based on Predominance and Components in Chinese Patients with Lung Adenocarcinoma
Presenter: Guomin Lin- Abstract
Loading... -
+
EP16.03-019 - Landscape of EGFR Extracellular Domain Mutations in Advanced Non Small Cell Lung Carcinoma
Presenter: Lesli A Kiedrowski- Abstract
Loading... -
+
EP16.03-020 - High Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC in Never Smokers is Associated with Worse Prognosis
Presenter: Louis-Jacques Ruel- Abstract
Loading... -
+
EP16.03-021 - Developing of EGFR resistant mutations to Tyrosine Kinase Inhibitors (TKI) in Non-Small Cell Lung Cancer (NSCLC)
Presenter: Luis Raez, MD, FACP, FCCP- Abstract
Loading... -
+
EP16.03-022 - Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Sampling Is Sufficient for Lung Cancer Molecular Profiling
Presenter: Luis Raez, MD, FACP, FCCP- Abstract
Loading... -
+
EP16.03-023 - KRAS Alterations, Clinicopathological Features and Co-occurring Drivers Associated with Prognosis in Advanced NSCLC Patients
Presenter: Maritza Ramos-Ramirez- Abstract
Loading... -
+
EP16.03-024 - Cellworks Singula™ Therapy Response Index (TRI) Identifies Superior OS Outcomes for NSCLC Patients: myCare-203A
Presenter: Mark Klein- Abstract
Loading... -
+
EP16.03-025 - Immunogenomics of Clinical Resistance to KRAS G12C Inhibition
Presenter: Mark Woodcock- Abstract
Loading... -
+
EP16.03-026 - Metastasis Sites and Genomic Alterations in Advanced Non Small Cell Lung Cancer: A Retrospective Study
Presenter: Juan Manuel Martínez-Valenciano- Abstract
Loading... -
+
EP16.03-027 - Routine Molecular Testing Using the TSO500+ NGS Panel in a Cohort of Patients with NSCLC
Presenter: Miguel Mosteiro Lamas- Abstract
Loading... -
+
EP16.03-028 - Cancer Cells May be Re-sensitized to Tumor Treating Fields (TTFields) Through Inhibition of the PI3K/AKT/mTOR Pathway
Presenter: Moshe Giladi- Abstract
Loading... -
+
EP16.03-029 - SLIT2 Expression in NSCLC With Long-Term Response to Pemetrexed
Presenter: Eiji Nakajima- Abstract
Loading... -
+
EP16.03-030 - AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma.
Presenter: Alvaro Quintanal-Villalonga- Abstract
Loading... -
+
EP16.03-031 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer Harboring Different EGFR Exon 19 Del/Delins Variants
Presenter: Shun Lu- Abstract
Loading... -
+
EP16.03-032 - Structure-Based Classification of Chinese Patients with Non-Canonical EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Shun Lu- Abstract
Loading... -
+
EP16.03-033 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups
Presenter: Shun Lu- Abstract
Loading... -
+
EP16.03-034 - Differential Prognostic Effect of EGFR Mutation According to Smoking Status and Pathologic Stage in Non-mucinous Lung Adenocarcinoma
Presenter: sukki Cho- Abstract
Loading... -
+
EP16.03-035 - Driver Mutations on Metastatic NSCLC - Experience in a Secondary Center
Presenter: Sofia Campos Silva- Abstract
Loading... -
+
EP16.03-036 - Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC
Presenter: Stephanie Pei Li Saw- Abstract
Loading... -
+
EP16.03-037 - Poor Prognosis of Patients with EGFR Mutations Left behind by Selective Detection in NSCLC
Presenter: Taisuke Matsubara- Abstract
Loading... -
+
EP16.03-038 - Single-cell Analyses Reveal Tumor Microenvironment Differences between EGFR 19del and L858R mutations in Lung Adenocarcinoma
Presenter: Tao Wang- Abstract
Loading... -
+
EP16.03-039 - Characterizing SHPRH as a Novel Tumor Suppressor Gene in Lung Adenocarcinoma
Presenter: Tianna Shindi Sihota- Abstract
Loading... -
+
EP16.03-040 - Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base
Presenter: Umberto Malapelle- Abstract
Loading... -
+
EP16.03-041 - Single Cell RNA Sequencing Reveals Phenotypic Predispositions to Developing Lung Cancer in Never-Smokers
Presenter: Venessa Chin- Abstract
Loading... -
+
EP16.03-042 - BET Inhibitors Stimulate NK Cytotoxic Activity in NSCLC through Attenuation of YAP/TAZ and SMAD3 Transcriptional Programs
Presenter: Valentina Sancisi- Abstract
Loading... -
+
EP16.03-043 - Comprehensive Genomic Profiling of Tumor Mutational Burden-high in Chinese Lung Cancer Patients
Presenter: Wei Li- Abstract
Loading... -
+
EP16.03-044 - Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma
Presenter: Yuchen Han- Abstract
Loading... -
+
EP16.03-045 - The Effect of Vascular Endothelial Growth Factor Gene Polymorphisms in the Clinical Outcome of Patients with Lung Cancer
Presenter: Younes El Founini- Abstract
Loading... -
+
EP16.03-046 - Tumor Grade Associated Genomic Mutations in Chinese Patients with Lung Cancer
Presenter: Min Zheng- Abstract
Loading... -
+
EP16.03-047 - Genomic Landscape of Squamous Cell Carcinoma Lung in an Indian Cohort
Presenter: Ullas Batra- Abstract
Loading...
-
+
EP16.04 - Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Tumour Biology & Preclinical Studies
-
+
EP16.04-001 - The Role of Stromal PDGFRβ-activation in NSCLC
Presenter: Amanda Lindberg- Abstract
Loading... -
+
EP16.04-002 - Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC
Presenter: Anne Petzold- Abstract
Loading... -
+
EP16.04-003 - High Dimensional Spatial Profiling of the NSCLC Tumour Microenvironment
Presenter: Arutha Kulasinghe- Abstract
Loading... -
+
EP16.04-004 - Impact of Gender on Cellular Response to Cigarette Smoke Extract
Presenter: Anne-Marie Baird- Abstract
Loading... -
+
EP16.04-005 - Investigating the Side Effects of Docetaxel on Rat Lung and Heart
Presenter: Berna Komurcuoglu- Abstract
Loading... -
+
EP16.04-006 - A Novel Orthotopic Xenograft Mouse Model to Study Lung Cancer-Associated Fibroblasts and Lymphangiogenesis
Presenter: Caoyang Chen- Abstract
Loading... -
+
EP16.04-007 - ALDH2 Downregulation, Aberrant DNA Methylation, and Loss of Stemness Pathways as an Enhanced Biomarker in Lung Adenocarcinoma
Presenter: Thi-Oanh Tran- Abstract
Loading... -
+
EP16.04-008 - Cytotoxic Effects of Carnosic Acid Are Mediated by Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling in H1299 NSCLC Cells
Presenter: Eric Jordan O'Neill- Abstract
Loading... -
+
EP16.04-009 - The Proliferative Effect of 27-Hydroxycholesterol as a Selective Estrogen Receptor Modulator on Pathology of NSCLC
Presenter: Ikki Takada- Abstract
Loading... -
+
EP16.04-010 - Histological and Genetic Parental Tumor Characteristics are Conserved in Patient-derived Non-small Cell Lung Cancer Organoids
Presenter: Isabelle Opitz- Abstract
Loading... -
+
EP16.04-011 - Sex Hormone Signalling in Lung Adenocarcinoma Limits Tumour Virulence
Presenter: John Le Quesne- Abstract
Loading... -
+
EP16.04-012 - Retrospective Analysis of Non-Small Cell Lung Cancer with Mucinous Histology Subtype
Presenter: Katherine Garcia- Abstract
Loading... -
+
EP16.04-013 - Spatial Multi-Omics Landscape of Radiologically Preinvasive/Invasive Lesion in Part-Solid Lung Adenocarcinoma
Presenter: Kwon Joong Na- Abstract
Loading... -
+
EP16.04-014 - NTRK in Lung Cancer Patients with History of Hodgkin's Lymphoma
Presenter: Mariola Blanco Clemente- Abstract
Loading... -
+
EP16.04-015 - Chemotherapy Upregulates Programmed Cell Death Ligand 1 Expression in Non-Small Cell Lung Cancer Cell Lines and Patient-Derived Organoid Models
Presenter: Maryam Khalil- Abstract
Loading... -
+
EP16.04-016 - Overexpression of CEACAM6 Activates Src-FAK Signaling and Inhibits Anoikis, through Homophilic Interactions in Lung Adenocarcinomas
Presenter: Eun Young Kim- Abstract
Loading... -
+
EP16.04-017 - Lineage Switching and Tumor Microenvironment Roles of Tumor Suppressors in Autochthonous Lung Cancer Models
Presenter: Nisitha Sengottuvel- Abstract
Loading... -
+
EP16.04-018 - DNA Mismatch Repair in Lung Adenocarcinoma in Morocco
Presenter: Ouassima Erefai- Abstract
Loading... -
+
EP16.04-019 - Impact of Chemotherapy on Tridimensional Multicellular Non-small Cell Lung Cancer Spheroids With Microenvironment Cells
Presenter: Pauline Hulo- Abstract
Loading... -
+
EP16.04-020 - Dysregulation of 14-3-3 Signaling Adapters in Lung Adenocarcinoma, New Insights Into the Impact on Cancer Cell Biology
Presenter: Rhys Hamon- Abstract
Loading... -
+
EP16.04-021 - Chromatin Remodeling Drives Lung Pre-malignancy and is a Target for Prevention
Presenter: Steven Belinsky- Abstract
Loading... -
+
EP16.04-022 - Prognosis of Epithelial-Mesenchymal Transition-Related lncRNA Profile in LUSC Patients
Presenter: Shanshan Xiao- Abstract
Loading... -
+
EP16.04-024 - HMGB1-mediated Autophagy Promotes Gefitinib Resistance in Human Non-small Cell Lung Cancer
Presenter: Zhaoxia Wang- Abstract
Loading... -
+
EP16.04-025 - Statins Suppress SOAT1 Expression & Reduce Cholesterol Esterification in Statin-sensitive Lung Cancer Cells
Presenter: Katsuhiko Warita- Abstract
Loading... -
+
EP16.04-026 - Effectiveness of Atorvastatin and SR-12813 Combination in Statin-resistant and Statin-sensitive Lung Cancer Cell Lines
Presenter: TOMOKO WARITA- Abstract
Loading... -
+
EP16.04-027 - Identification of Optimal Internal Reference Gene to Analyze the Anticancer Effects of Statins in Lung Cancer Cells
Presenter: TOMOKO WARITA- Abstract
Loading... -
+
EP16.04-028 - PHLPP2 Regulates Ferroptosis Through Nrf2 Pathway to Affected Cell Cycle and Apoptosisin Lung Squamous Cell Carcinoma
Presenter: Haihua Yang- Abstract
Loading... -
+
EP16.04-029 - Downregulation of PHLPP2 Induced by Radiation Promotes GPX4-mediated Ferroptosis Defense and Radioresistance in Lung Cancer
Presenter: Haihua Yang- Abstract
Loading... -
+
EP16.04-030 - Cancer-Associated Fibroblasts Attenuate DNA Damage Repair by Promoting Glycolysis in Non-small Cell Lung Cancer
Presenter: hongfang zhang- Abstract
Loading... -
+
EP16.04-031 - Connexin 43 Overexpression Induces Angiogenesis in Vitro Following Phosphorylation at Ser279 in its C Terminus
Presenter: Zizi Zhou- Abstract
Loading... -
+
EP16.04-032 - Indoleamine 2,3-dioxygenase 1 (IDO1) Blood Metabolites May Improve Predictive Accuracy for Radiation Pneumonitis
Presenter: Feng-Ming Spring Kong- Abstract
Loading...
first
prev
